GM-CSF has been shown to be effective in the treatment of severe mucositis in patients who have undergone bone marrow transplantation (Nemunaitis et al. 1995), although it does not reduce radiation-induced mucositis, according to the one prospective randomized study (Makkonen et al. 2000). This evidence concerns the gene CSF2 and mucositis.